[1] |
段纪俊,严亚琼,杨念念,等. 中国恶性肿瘤发病与死亡的国际比较分析[J]. 中国医学前沿杂志(电子版),2016,8(7):17-23.
|
[2] |
LIANG Z,CHENG Y,CHEN Y,et al.EGFR T790M ctDNA testing platforms and their role as companion diagnostics:correlation with clinical outcomes to EGFR-TKIs[J]. Cancer Lett,2017,403:186-194.
|
[3] |
ALIX-PANABIÈRES C,PANTEL K. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy[J]. Cancer Discov,2016,6(5):479-491.
|
[4] |
林铖,姜傥. 液体活检技术在非小细胞肺癌患者EGFR-TKI继发耐药中的应用[J]. 检验医学,2016,31(10):835-843.
|
[5] |
ROLFO C,CASTIGLIA M,HONG D,et al.Liquid biopsies in lung cancer:the new ambrosia of researchers[J]. Biochim Biophys Acta,2014,1846(2):539-546.
|
[6] |
胥明勇,吴泳桦,朱华强. PCR抑制物干扰HBV DNA试剂检测能力评价[J]. 四川医学,2019,40(5):522-524.
|
[7] |
中华人民共和国国家卫生和计划生育委员会. WS/T 416—2013 干扰实验指南[S]. 北京:中华人民共和国国家卫生和计划生育委员会,2013.
|
[8] |
尚红,王毓三,申子瑜. 全国临床检验操作规程[M]. 4版. 北京:人民卫生出版社,2015.
|
[9] |
PAO W,MILLER V A,POLITI K A,et al.Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain[J]. PLoS Med,2005,2(3):e73.
|
[10] |
DIAZ L A Jr,BARDELLI A. Liquid biopsies:genotyping circulating tumor DNA[J]. J Clin Oncol,2014,32(6):579-586.
|
[11] |
DUAN H,LU J,LU T,et al.Comparison of EGFR mutation status between plasma and tumor tissue in non-small cell lung cancer using the Scorpion ARMS method and the possible prognostic significance of plasma EGFR mutation status[J]. Int J Clin Exp Pathol,2015,8(10):13136-13145.
|
[12] |
PFISTER D G,JOHNSON D H,AZZOLI C G,et al.American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline:update 2003[J]. J Clin Oncol,2004,22(2):330-353.
|
[13] |
卢鉴财,黄俊,徐韫健,等. Super-ARMS法在检测非小细胞肺癌EGFR基因突变中的应用分析[J]. 热带医学杂志,2019,19(4):430-433.
|
[14] |
李顺君,左玥. 临床血液标本不合格的原因及干预措施有效性分析[J]. 检验医学与临床,2019,16(4):536-539.
|
[15] |
袁凤喜,薛雄燕,陈彩凤,等. 溶血对液相色谱串联质谱检测血浆中儿茶酚胺及其代谢产物的影响[J]. 检验医学,2018,33(12):1103-1107.
|
[16] |
沈克锋,杨默,江千里. 血液和骨髓标本中常见PCR反应抑制物的探究与分析[J]. 中国实验血液学杂志,2014,22(3):842-846.
|
[17] |
OZDARENDELI A,TOROMAN Z A,BULUT Y,et al.Combined branched-DNA and conventional HBV PCR assays for detection of serum HBV-DNA in hepatitis B E antigen-positive chronic hepatitis B patients[J]. Hepatogastroenterology,2006,53(67):106-109.
|
[18] |
刘小敏,唐恒锋,李文郎,等. 高脂血、溶血标本对荧光定量聚合酶链反应测定低水平HBV-DNA的影响[J]. 检验医学与临床,2015,12(21):3217-3218.
|
[19] |
PORTILHO M M,MARTINS P P,LAMPE E,et al.A comparison of molecular methods for hepatitis B virus(HBV) DNA detection from oral fluid samples[J]. J Med Microbiol,2012,61(Pt 6):844-851.
|